| [1] |
Axelrod D, Smith J, Kornreich D, et al. Breast cancer in young women[J]. J Am Coll Surg,2008,206(6):1193-1203.
|
| [2] |
Lhommé C, Pautier P, Zagamé L, et al. Endometrial surveillance of women on tamoxifen[J]. Gynecol Obstet Fertil,2003,31(7/8):647-656.
|
| [3] |
Wu H, Chen Y, Liang J, et al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis[J]. Nature,2005,438(7070):981-987.
|
| [4] |
Gardner FJ, Konje JC, Bell SC, et al. Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system Long-term follow-up of a randomised control trial[J]. Gynecol Oncol,2009,114(3):452-456.
|
| [5] |
Chan SS, Tam WH, Yeo W, et al. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women[J]. BJOG,2007,114(12):1510-1515.
|
| [6] |
Wong AW, Chan SS, Yeo W, et al. Prophylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial[J]. Obstet Gynecol,2013,121(5):943-950.
|
| [7] |
纪新强,孙国臻. 三苯氧胺治疗乳腺癌引发卵巢囊肿的临床分析[J].中国综合临床,2003,19(7):660-661.
|
| [8] |
Mofrad MH, Shandiz FH, Roodsare FV. Evaluation of ovarian cysts in breast cancer cases on tamoxifen[J]. Asian Pac J Cancer Prev,2010,11(1):161-164.
|
| [9] |
孙正怡,沈铿,郎景和,等. 卵巢恶性肿瘤患者保留生育功能手术后化疗对卵巢功能的影响[J]. 中国医学科学院学报,2003,25(4):431-433.
|
| [10] |
Blumenfeld Z. Chemotherapy and fertility[J]. Best Pract Res Clin Obstet Gynaecol,2012,26(3):379-390.
|
| [11] |
Pagani O, Partridge A, Korde L, et al. Pregnancy after breast cancer: if you wish, ma’am[J]. Breast Cancer Res Treat,2011,129(2):309-317.
|
| [12] |
Gwyn K. Children exposed to chemotherapy in utero[J]. J Natl Cancer Inst Monogr,2005,(34):69-71.
|
| [13] |
Blumenfeld Z, Eckman A. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a[J]. J Natl Cancer Inst Monogr,2005, (34):40-43.
|
| [14] |
Del Mastro L, Boni L, Michelotti A. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial[J]. JAMA,2011,306(3):269-276.
|
| [15] |
LHRH-agonists in Early Breast Cancer Overview group, Cuzick J, Ambroisine L, et al. Use of luteinizing hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone receptor positive breast cancer: a metaanalysis of individual patient data from randomised adjuvant trials[J]. Lancet,2007,369(9574):1711-1723.
|
| [16] |
Howell A. Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer[J]. Breast Cancer Res,2007,9(Suppl 1):12.
|
| [17] |
Del Mastro L, Venturini M, Sertoli MR, et al. Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications[J]. Breast Cancer Res Treat,1997,43(2):183-190.
|
| [18] |
Maltaris T, Weigel M, Mueller A. Cancer and fertility preservation:fertility preservation in breast cancer patients[J].Breast Cancer Res,2008,10(2):206.
|
| [19] |
Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients:a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation[J]. J Clin Oncol,2005,23(19):4347-4353.
|
| [20] |
Azim HA Jr, Santoro L, Pavlidis N,et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies[J]. Eur J Cancer,2011,47(1):74-83.
|
| [21] |
Holmberg L, Anderson H, HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped[J]. Lancet,2004,363(9407):453-455.
|
| [22] |
von Schoultz E, Rutqvist LE. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial[J]. J Natl Cancer Inst,2005,97(7):533-535.
|
| [23] |
Sestak I, Kealy R, Edwards R,et al. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms[J]. J Clin Oncol,2006,24 (24):3991-3996.
|
| [24] |
Holmberg L,Iversen OE,Rudenstam CM,et al. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors[J]. J Natl Cancer Inst,2008,100(7):475-482.
|
| [25] |
Madalinska JB, van Beurden M, Bleiker E, et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingooophorectomy[J]. J Clin Oncol,2006,24(22):3576-3582.
|
| [26] |
Chiarelli AM, Kirsh VA, Klar NS, et al. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection[J]. Cancer Epidemiol Biomarkers Prev,2006,15(10):1856-1862.
|
| [27] |
Holleb AI.Breast cancer and pregnancy[J].CA Cancer J Clin,1965,15(4):182-183.
|
| [28] |
Azim HA, Peccatori FA, de Azambuja E,et al. Motherhood after breast cancer: searching for la dolce vita[J]. Expert Rev Anticancer Ther,2011,11(2):287-298.
|
| [29] |
Korman N, Jensen MB, Wohlfahrt J, et al. Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group [J]. Acta Oncol,2008,47(4):545-549.
|
| [30] |
Ives A,Saunders C,Bulsara M,et al. Pregnancy after breast cancer:Population based study[J].BMJ,2006,224(7586):194.
|
| [31] |
Yuri T,Tsukamoto R,Miki K,et al. Biphasic effects of zerona on the growth of estrogen receptor-positive human breast carcinoma cells[J].Oncol Rep,2006,16(6):1307-1312.
|
| [32] |
Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: healthy mother effect[J]. Am J Obstet Gynecol,1994,170(3):818-823.
|
| [33] |
Blakely LJ,Buzdar AU,Lozada JA,et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence[J].Cancer,2004,100(3):465-469.
|
| [34] |
Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer--a population-based cohort study from Sweden[J]. PLoS Med,2006,3(9):336.
|
| [35] |
Collaborative Group on Hormonal Factors in Breast Cancer.Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease[J].Lancet,2001,358(9291):1389-1399.
|
| [36] |
Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study[J]. J Clin Oncol,2008,26(16):2630-2635.
|
| [37] |
Gelber S, Coates AS, Goldhirsch A, et al. Effect of pregnancy on overall survival after the diagnosis of early stage breast cancer[J]. J Clin Oncol,2001,19(6):1671-1675.
|